CNS Virtual Matchmaking Event

Expression of interest in virtual meetings

This survey aims to collect your partnering requests to be submitted to the companies listed below.

The final partnering meeting is subject to acceptance by the company you request, so please add as much information as possible about your company to help them make a decision.

The full description of companies is available at this address: http://www.cebr.net/cns-profiles

You will be notified after the 10 April of acceptance of your meeting requests.

Your availability on 19/20th April will then be requested and meeting times confirmed

Individual names and contact details will be supplied to participating companies you have agreed to meet. All information supplied will be retained in accordance with EU funding requirements.

* indicates mandatory fields

Question Title

* 1. Company name

Question Title

* 2. Company address and website

Question Title

* 3. Name of partnering contact and e-mail address

Question Title

* 4. Preferred contact option (you can select both)

Skype (please provide skype ID)

Telephone (please provide direct telephone number)

Question Title

* 5. Company description (max 200 words)

Question Title

* 6. Please indicate here the companies you are interested in meeting

Aston University. University with Neuroscience research expertise in particular neurodevelopment (ADHD, dyslexia, autism, developmental coordination disorder), epilepsy, neuroimaging. TECHNOLOGY 1

Aston University. University with Neuroscience research expertise in particular neurodevelopment (ADHD, dyslexia, autism, developmental coordination disorder), epilepsy, neuroimaging. TECHNOLOGY 2

Aston University. University with Neuroscience research expertise in particular neurodevelopment (ADHD, dyslexia, autism, developmental coordination disorder), epilepsy, neuroimaging. TECHNOLOGY 3

AxoGlia Therapeutics SA. Drives the development of CNS regenerative treatments for neurological diseases such as Parkinson’s disease and Multiple Sclerosis.

Biognos AB. Biognos AB is focused on computational screening, both ligand-based (similarity searches) and structure-based (docking) using large databases of small molecules

Cambridge Enterprise. Cambridge Enterprise is the technology transfer company for the University of Cambridge and exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.

EPHORAN Multi-Imaging Solutions. Contract Research Organization in preclinical imaging

Imanova. Imanova is a world-leading research centre for imaging sciences and their application to drug development.

Informatics Research Institute (IRI). SME focused on research, training and consulting in Computer Science, with large expertise in ICT for Health and a special interest on Clinical Decision Support Systems.

Metabolys. Metabolys uses cellular metabolomics to identify and quantify metabolic pathways in cerebral cells.

Neurofit SAS. CRO specialized in Neurosciences

Neurotec Pharma SL. Development of treatments for CNS diseases that occur with inflammation and neurodegeneration.

Pharmidex. Pharmidex is a CNS specialist ADMET/PK provider.

Pronexus Analytical AB. Pronexus Analytical is a preclinical CRO specialized on services for rapid screening of drug effects in CNS and inflammatory disease models by in vivo techniques

QCTR Ltd. A CRO specialising in neurology, psychiatry and orphan diseases, running phase II and III trials.

Redoxis AB. Preclinical validation of treatment efficacy in experimental allergic encephalomyelitis (EAE) an animal model for Multiple Sclerosis (MS).

SATT Conectus Alsace. The TTO SATT Conectus Alsace®, Reinforcing partnerships between research and industry & Transferring specific know-how, skills and technologies developed through our own research.

Senexis Limited. Developing oral drugs for the disease-modifying treatment of Alzheimer's disease

SynapCell SAS. SynapCell is a preclinical Contract Research Organisation focused on preclinical validation of compounds targeting CNS pathologies. Through highly predictive tests, the company offers smart solutions to customer’s problems, together with optimised costs.

Umecrine AB. Treatment against stress and sex steroid induced disorders

Comments